We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Water-Soluble Peptides with Stable Helical Structure Are Potential Nanoparticle Carriers

By LabMedica International staff writers
Posted on 15 Mar 2011
A paper describes the synthesis of peptides with stable helical structure that may serve as nanoparticle carriers for drug and gene delivery.

Water-soluble peptides with stable helical structure are of interest to protein chemists because of their importance in basic science and their broad utility in medicine and biotechnology. More...
Incorporating charged amino-acid residues to improve peptide solubility, however, usually leads to reduced helical stability because of increased side-chain charge repulsion, reduced side-chain hydrophobicity, and the disruption of intramolecular hydrogen bonding.

In the current study, published in the February 22, 2011, online edition of the journal Nature Communications, investigators at the University of Illinois (Urbana-Champaign, USA) showed that water-soluble, ultra-stable alpha-helical polypeptides could be produced by elongating charge-containing amino-acid side chains to position the charges far removed from the polypeptide backbone. As the length of the side chains with charges on the end increased, the tendency of the polypeptides to form helices also increased. The helices prepared by this method displayed remarkable stability even when compared to noncharged helices and were resistant to temperature, pH, and other denaturing agents that would denature most polypeptides.

"You can achieve the helical structure and the solubility but you have to design the helical structure in a very special way. The peptide design needs a very specific sequence. Then you are very limited in the type of polypeptide you can build, and it is not easy to design or handle these polypeptides,” said senior author Dr. Jianjun Cheng, professor of materials science and engineering at the University of Illinois. "It is such a simple idea – move the charge away from the backbone. It is not difficult at all to make the longer side chains, and it has amazing properties for winding up helical structures simply by pushing the distance between the charge and the backbone.”

"We want to test the correlation of the lengths of the helices and the circulation in the body to see what is the impact of the shape and the charge and the side chains for clearance in the body,” said Dr. Cheng. "Recent studies show that the aspect ratio of the nanostructures – spherical structures versus tubes – has a huge impact on their penetration of tumor tissues and circulation half-lives in the body.”

Related Links:

University of Illinois




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.